New drug combo tested in fight against rapid ALS form
Disease control
Completed
This study tested whether adding a new drug called IFB-088 to the standard medication riluzole could help people with a specific, rapidly progressing form of ALS that starts with speech and swallowing problems. 51 participants were randomly assigned to receive either IFB-088 or a…
Phase: PHASE2 • Sponsor: InFlectis BioScience • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC